Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | ALS2 CL E G H | 57679 | 443 | OMIM:606353 | Primary lateral sclerosis, juvenile | | | | 114 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | ATL1 CL E G H | 51062 | 11231 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | | | | 71 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | ATL3 CL E G H | 25923 | 24526 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | | | | 5 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | ATXN1 CL E G H | 6310 | 10548 | OMIM:164400 | Spinocerebellar ataxia 1 | | | | 19 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | BSCL2 CL E G H | 26580 | 15832 | OMIM:619112 | NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VC; HMN5C | | | | 105 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | CADM3 CL E G H | 57863 | 17601 | OMIM:619519 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF; CMT2FF | | | | 1 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | CCT5 CL E G H | 22948 | 1618 | OMIM:256840 | Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive | | | | 56 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | DHX16 CL E G H | 8449 | 2739 | OMIM:618733 | NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS | | | | | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | DNAJB6 CL E G H | 10049 | 14888 | OMIM:603511 | Muscular dystrophy, limb-girdle, type 1E | | | | 103 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | EMILIN1 CL E G H | 11117 | 19880 | OMIM:620080 | | | | | 2 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | FXN CL E G H | 2395 | 3951 | OMIM:229300 | Friedreich ataxia 1 | | | | 18 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | GDAP1 CL E G H | 54332 | 15968 | OMIM:607706 | Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomalrecessive | | | | 108 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | HK1 CL E G H | 3098 | 4922 | ORPHA:99953 | Charcot-Marie-Tooth disease type 4G | | | | 11 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | HSPB8 CL E G H | 26353 | 30171 | OMIM:608673 | Charcot-Marie-Tooth disease, axonal, type 2L | | | | 38 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | KARS1 CL E G H | 3735 | 6215 | OMIM:613641 | Charcot-marie-tooth disease, recessive intermediate B | | | | | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | LITAF CL E G H | 9516 | 16841 | OMIM:601098 | Charcot-Marie-Tooth disease, demyelinating, type 1C | | | | 74 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:98856 | Charcot-Marie-Tooth disease type 2B1 | | | | 645 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | MORC2 CL E G H | 22880 | 23573 | ORPHA:466768 | Autosomal dominant Charcot-Marie-Tooth disease type 2Z | | | | 8 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | MORC2 CL E G H | 22880 | 23573 | OMIM:616688 | Charcot-Marie-Tooth disease, axonal, type 2Z | | | | 8 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | NDRG1 CL E G H | 10397 | 7679 | ORPHA:99950 | Charcot-Marie-Tooth disease type 4D | | | | 82 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | NEFL CL E G H | 4747 | 7739 | OMIM:607684 | Charcot-Marie-Tooth disease, axonal, type 2E | | | | 118 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | PMP2 CL E G H | 5375 | 9117 | OMIM:618279 | Charcot-Marie-Tooth disease, demyelinating, type 1G | | | | 1 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | RAB7A CL E G H | 7879 | 9788 | OMIM:600882 | Charcot-Marie-Tooth disease, axonal, type 2B | | | | 50 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | RFC1 CL E G H | 5981 | 9969 | OMIM:614575 | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome | | | | | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | SBF2 CL E G H | 81846 | 2135 | ORPHA:99956 | Charcot-Marie-Tooth disease type 4B2 | | | | 180 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | SETX CL E G H | 23064 | 445 | OMIM:602433 | Amyotrophic lateral sclerosis 4, juvenile | | | | 162 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | SORD CL E G H | 6652 | 11184 | OMIM:618912 | SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY; SORDD | | | | | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | SPTLC1 CL E G H | 10558 | 11277 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | | | | 54 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | SPTLC2 CL E G H | 9517 | 11278 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | | | | 149 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | SYT2 CL E G H | 127833 | 11510 | OMIM:616040 | Myasthenic syndrome, congenital, 7, presynaptic | | | | 4 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | TFG CL E G H | 10342 | 11758 | ORPHA:90117 | Hereditary motor and sensory neuropathy, Okinawa type | HP:0040281 - Very frequent | | | 18 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | TRPV4 CL E G H | 59341 | 18083 | OMIM:606071 | Hereditary motor and sensory neuropathy, type IIC | | | | 214 | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | UQCRC1 CL E G H | 7384 | 12585 | OMIM:619279 | PARKINSONISM WITH POLYNEUROPATHY; PKNPY | | | | | | |
HP:0030179 | HP:0030179 | Abnormal peripheral action potential amplitude | 0 | VPS13A CL E G H | 23230 | 1908 | ORPHA:2388 | Choreoacanthocytosis | | | | 130 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | ALS2 CL E G H | 57679 | 443 | OMIM:606353 | Primary lateral sclerosis, juvenile | | | | 114 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | ATL1 CL E G H | 51062 | 11231 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | HP:0040281 - Very frequent | | | 71 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | ATL3 CL E G H | 25923 | 24526 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | HP:0040281 - Very frequent | | | 5 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | ATXN1 CL E G H | 6310 | 10548 | OMIM:164400 | Spinocerebellar ataxia 1 | | | | 19 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | BSCL2 CL E G H | 26580 | 15832 | OMIM:619112 | NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VC; HMN5C | | | | 105 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | CADM3 CL E G H | 57863 | 17601 | OMIM:619519 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF; CMT2FF | | | | 1 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | CCT5 CL E G H | 22948 | 1618 | OMIM:256840 | Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive | | | | 56 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | DHX16 CL E G H | 8449 | 2739 | OMIM:618733 | NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS | | | | | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | DNAJB6 CL E G H | 10049 | 14888 | OMIM:603511 | Muscular dystrophy, limb-girdle, type 1E | | | | 103 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | EMILIN1 CL E G H | 11117 | 19880 | OMIM:620080 | | | | | 2 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | FXN CL E G H | 2395 | 3951 | OMIM:229300 | Friedreich ataxia 1 | | | | 18 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | GDAP1 CL E G H | 54332 | 15968 | OMIM:607706 | Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomalrecessive | | | | 108 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | HK1 CL E G H | 3098 | 4922 | ORPHA:99953 | Charcot-Marie-Tooth disease type 4G | | | | 11 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | HSPB8 CL E G H | 26353 | 30171 | OMIM:608673 | Charcot-Marie-Tooth disease, axonal, type 2L | . | | | 38 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | KARS1 CL E G H | 3735 | 6215 | OMIM:613641 | Charcot-marie-tooth disease, recessive intermediate B | | | | | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | LITAF CL E G H | 9516 | 16841 | OMIM:601098 | Charcot-Marie-Tooth disease, demyelinating, type 1C | | | | 74 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:98856 | Charcot-Marie-Tooth disease type 2B1 | | | | 645 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | MORC2 CL E G H | 22880 | 23573 | ORPHA:466768 | Autosomal dominant Charcot-Marie-Tooth disease type 2Z | | | | 8 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | MORC2 CL E G H | 22880 | 23573 | OMIM:616688 | Charcot-Marie-Tooth disease, axonal, type 2Z | | | | 8 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | NDRG1 CL E G H | 10397 | 7679 | ORPHA:99950 | Charcot-Marie-Tooth disease type 4D | HP:0040281 - Very frequent | | | 82 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | NEFL CL E G H | 4747 | 7739 | OMIM:607684 | Charcot-Marie-Tooth disease, axonal, type 2E | | | | 118 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | PMP2 CL E G H | 5375 | 9117 | OMIM:618279 | Charcot-Marie-Tooth disease, demyelinating, type 1G | | | | 1 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | RAB7A CL E G H | 7879 | 9788 | OMIM:600882 | Charcot-Marie-Tooth disease, axonal, type 2B | | | | 50 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | RFC1 CL E G H | 5981 | 9969 | OMIM:614575 | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome | | | | | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | SBF2 CL E G H | 81846 | 2135 | ORPHA:99956 | Charcot-Marie-Tooth disease type 4B2 | | | | 180 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | SETX CL E G H | 23064 | 445 | OMIM:602433 | Amyotrophic lateral sclerosis 4, juvenile | | | | 162 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | SORD CL E G H | 6652 | 11184 | OMIM:618912 | SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY; SORDD | | | | | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | SPTLC1 CL E G H | 10558 | 11277 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | HP:0040281 - Very frequent | | | 54 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | SPTLC2 CL E G H | 9517 | 11278 | ORPHA:36386 | Hereditary sensory and autonomic neuropathy type 1 | HP:0040281 - Very frequent | | | 149 | | |
HP:0030179 | HP:0025680 | Compound muscle action potential amplitude facilitation | 1 | SYT2 CL E G H | 127833 | 11510 | OMIM:616040 | Myasthenic syndrome, congenital, 7, presynaptic | | | | 4 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | SYT2 CL E G H | 127833 | 11510 | OMIM:616040 | Myasthenic syndrome, congenital, 7, presynaptic | | | | 4 | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | TRPV4 CL E G H | 59341 | 18083 | OMIM:606071 | Hereditary motor and sensory neuropathy, type IIC | | | | 214 | | |
HP:0030179 | HP:0033383 | Decreased compound muscle action potential amplitude | 1 | UQCRC1 CL E G H | 7384 | 12585 | OMIM:619279 | PARKINSONISM WITH POLYNEUROPATHY; PKNPY | | | | | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | UQCRC1 CL E G H | 7384 | 12585 | OMIM:619279 | PARKINSONISM WITH POLYNEUROPATHY; PKNPY | | | | | | |
HP:0030179 | HP:0007078 | Decreased amplitude of sensory action potentials | 1 | VPS13A CL E G H | 23230 | 1908 | ORPHA:2388 | Choreoacanthocytosis | HP:0040282 - Frequent | | | 130 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | GDAP1 CL E G H | 54332 | 15968 | OMIM:607706 | Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomalrecessive | | | | 108 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | HK1 CL E G H | 3098 | 4922 | ORPHA:99953 | Charcot-Marie-Tooth disease type 4G | HP:0040281 - Very frequent | | | 11 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | LITAF CL E G H | 9516 | 16841 | OMIM:601098 | Charcot-Marie-Tooth disease, demyelinating, type 1C | | | | 74 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | MORC2 CL E G H | 22880 | 23573 | ORPHA:466768 | Autosomal dominant Charcot-Marie-Tooth disease type 2Z | HP:0040282 - Frequent | | | 8 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | NEFL CL E G H | 4747 | 7739 | OMIM:607684 | Charcot-Marie-Tooth disease, axonal, type 2E | | | | 118 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | RFC1 CL E G H | 5981 | 9969 | OMIM:614575 | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome | | | | | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | SBF2 CL E G H | 81846 | 2135 | ORPHA:99956 | Charcot-Marie-Tooth disease type 4B2 | | | | 180 | | |
HP:0030179 | HP:0007230 | Decreased distal sensory nerve action potential | 2 | TRPV4 CL E G H | 59341 | 18083 | OMIM:606071 | Hereditary motor and sensory neuropathy, type IIC | . | | | 214 | | |